Moderna Names New CFO as Vaccine Testing Enters Crucial Phase

(Bloomberg) -- Moderna Inc. named a new chief financial officer as the biotechnology’s coronavirus vaccine moved ahead in wider testing that will determine how safe and effective it is.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.